ROCKWELL MEDICAL, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
ROCKWELL MEDICAL, INC. (RMTI) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $20.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2017-03-15
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $20.00K, a 97.93% decline from fiscal 2015.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $968.00K, a 51.82% decline from fiscal 2014.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $2.01M, a 229.89% increase from fiscal 2013.
- ROCKWELL MEDICAL, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $609.00K, a 23.28% increase from fiscal 2012.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 0 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|
| 2016-12-31 | $20.00K 10-K · filed 2017-03-15 | ||
| 2015-12-31 | $968.00K 10-K · filed 2016-02-29 | ||
| 2014-12-31 | $2.01M 10-K · filed 2017-03-15 | $3.23M 10-K · filed 2015-03-03 | |
| 2013-12-31 | $609.00K 10-K · filed 2016-02-29 | ||
| 2012-12-31 | $2.40M 10-K · filed 2013-03-18 | $494.00K 10-K · filed 2015-03-03 | |
| 2011-12-31 | $772.00K 10-K · filed 2014-03-07 | ||
| 2010-12-31 | $125.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |